145
Antonia S. New, Marianne Goodman, Joseph Triebwasser, et al., “Recent Advances in the Biological Study of Personality Disorders,”
146
Bonnie Jean Steinberg, Robert L. Trestman, and Larry J. Siever, “The Cholinergic and Noradrenergic Neurotransmitter Systems and Affective Instability in Borderline Personality Disorder,” in
147
Mary C. Zanarini, Catherine R. Kimble, and Amy A. Williams, “Neurological Dysfunction in Borderline Patients and Axis II Control Subjects,”
148
Jose Manuel de la Funete, Julio Bobes, Coro Vizuete, et al., “Neurologic Soft Signs in Borderline Personality Disorder,”
149
Eric Lis, Brian Greenfield, Melissa Henry, et al., “Neuroimaging and Genetics of Borderline Personality Disorder: A Review,”
150
American Psychiatric Association, “Practice Guideline for the Treatment of Patients with Borderline Personality Disorder,”
151
Mary C. Zanarini and Frances R. Frankenburg, “Omega-3 Fatty Acid Treatment of Women with Borderline Personality Disorder: A Double-Blind Placebo-